Apr 07, 2021 7:30am EDT Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical
Apr 07, 2021 7:30am EDT Mydecine Announces API-naming structure of Four Lead Candidates and Prepares for Pre-IND
Mar 01, 2021 7:30am EST Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain
Feb 17, 2021 7:00am EST Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology
Feb 01, 2021 7:30am EST Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange
Jan 28, 2021 7:30am EST Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland